NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 133,225 Value ($000) $212 Avg Close — Range —
Q4 2023
Shares 139,090 Value ($000) $119 Avg Close — Range —
Q3 2023
Shares 139,145 Value ($000) $149 Avg Close — Range —
Q2 2023
Shares 139,536 Value ($000) $361 Avg Close — Range —
Q1 2023
Shares 132,694 Value ($000) $541 Avg Close — Range —
Q4 2022
Shares 133,415 Value ($000) $670 Avg Close — Range —
Q3 2022
Shares 150,629 Value ($000) $1,970 Avg Close — Range —
Q2 2022
Shares 130,789 Value ($000) $1,677 Avg Close — Range —
Q1 2022
Shares 132,514 Value ($000) $2,021 Avg Close — Range —
Q4 2021
Shares 128,621 Value ($000) $2,278 Avg Close — Range —
Q3 2021
Shares 117,234 Value ($000) $2,465 Avg Close — Range —
Q2 2021
Shares 101,391 Value ($000) $2,000 Avg Close — Range —
Q1 2021
Shares 79,756 Value ($000) $2,318 Avg Close — Range —
Q4 2020
Shares 83,155 Value ($000) $2,519 Avg Close — Range —
Q3 2020
Shares 85,046 Value ($000) $1,353 Avg Close — Range —
Q2 2020
Shares 81,189 Value ($000) $1,603 Avg Close — Range —
Q1 2020
Shares 82,295 Value ($000) $1,015 Avg Close — Range —
Q4 2019
Shares 58,728 Value ($000) $1,085 Avg Close — Range —
Q3 2019
Shares 24,937 Value ($000) $345 Avg Close — Range —
Q2 2019
Shares 12,009 Value ($000) $176 Avg Close — Range —